197 related articles for article (PubMed ID: 28219875)
1. [Prognostic value of circulating tumor cells and disseminated tumor cells in patients with esophageal cancer: a meta-analysis].
Shi XX; An JH; Huang YE; Zhang YZ; Huang ZY; Zou ZN; Chen Q; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):266-273. PubMed ID: 28219875
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature.
Wang S; Zheng G; Cheng B; Chen F; Wang Z; Chen Y; Wang Y; Xiong B
PLoS One; 2014; 9(6):e99259. PubMed ID: 24901848
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic value of circulating tumor cells in esophageal carcinoma: a meta-analysis.
Zhang Y; Deng H; Chen G; Tang Z; Mao J; Mi Y; Cui S; Zhang Y; Wang N; Wang L
Ann Palliat Med; 2020 Nov; 9(6):4271-4282. PubMed ID: 33183057
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of circulating tumor cells in esophageal cancer.
Xu HT; Miao J; Liu JW; Zhang LG; Zhang QG
World J Gastroenterol; 2017 Feb; 23(7):1310-1318. PubMed ID: 28275311
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis.
Huang X; Gao P; Sun J; Chen X; Song Y; Zhao J; Xu H; Wang Z
Int J Cancer; 2015 Jan; 136(1):21-33. PubMed ID: 24803400
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
Li Y; Wu G; Yang W; Wang X; Duan L; Niu L; Zhang Y; Liu J; Hong L; Fan D
BMC Cancer; 2020 Jun; 20(1):581. PubMed ID: 32571299
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis.
Hou J; Zou K; Yang C; Leng X; Xu Y
Onco Targets Ther; 2018; 11():8053-8061. PubMed ID: 30519047
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis.
Li B; Xiong F; Yi S; Wang S
Technol Cancer Res Treat; 2022; 21():15330338211070140. PubMed ID: 35025614
[No Abstract] [Full Text] [Related]
12. Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis.
Qiao GL; Qi WX; Jiang WH; Chen Y; Ma LJ
Onco Targets Ther; 2016; 9():1889-97. PubMed ID: 27099520
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
[TBL] [Abstract][Full Text] [Related]
14. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.
Wang S; Du H; Li G
Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659
[TBL] [Abstract][Full Text] [Related]
15. Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.
Stephenson D; Nahm C; Chua T; Gill A; Mittal A; de Reuver P; Samra J
Oncotarget; 2017 Dec; 8(63):107223-107236. PubMed ID: 29291024
[TBL] [Abstract][Full Text] [Related]
16. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
19. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis.
Wang J; Wang K; Xu J; Huang J; Zhang T
PLoS One; 2013; 8(11):e78070. PubMed ID: 24223761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
